No single test can definitively prove your cancer is gone. Doctors use a combination of imaging scans, blood tests, biopsies, and physical exams to look for any remaining cancer cells, and if none are found, they’ll tell you there is “no evidence of disease.” That phrase is carefully chosen. Even after successful treatment, doctors generally won’t say you’re cured, because microscopic cancer cells can remain undetectable in the body for years. What they can say is that right now, with every tool available, they can’t find any signs of cancer.
What “Gone” Actually Means in Medical Terms
You’ll hear several terms after treatment, and they mean different things. Partial remission means your cancer has shrunk but hasn’t disappeared entirely. Complete remission means all signs and symptoms of cancer are gone on every test your doctors run. “No evidence of disease,” or NED, means the same thing as complete remission: nothing shows up.
None of these terms mean cured. The National Cancer Institute defines a cure as no traces of cancer remaining, with the cancer never coming back. Doctors rarely use this word because some cancer cells can linger in the body for years without being detected. If you remain in complete remission for five years or more, some doctors may start using the word “cured,” especially for cancers that rarely return after that window. But for other cancer types, recurrence can happen a decade or more after treatment. So for most people, the honest answer is: your doctors are looking for evidence that cancer still exists, and when they can’t find any, that’s the best news available.
How Imaging Scans Check for Remaining Cancer
The most common way to look for leftover cancer is through imaging. CT scans, PET scans, and MRIs each have strengths, and your follow-up plan will likely include one or more of these depending on your cancer type.
CT scans can detect masses as small as about 3 millimeters. MRI systems have similar detection limits. PET scans work differently: they detect metabolic activity, essentially showing whether cells in a specific area are consuming energy at rates typical of cancer. Modern PET scanners can pick up tumors as small as 7 millimeters in diameter under typical clinical conditions, and they’re especially useful for distinguishing active cancer from scar tissue that a CT might flag as suspicious.
The key limitation is size. If a cluster of cancer cells is smaller than what these machines can resolve, it won’t show up. A clear scan means no detectable tumors, not necessarily zero cancer cells in your body. This is why doctors schedule repeated scans over months and years rather than relying on a single “all clear” result.
Blood Tests That Track Cancer Activity
For many cancer types, specific proteins or other substances in your blood rise when cancer is active and fall when treatment is working. These are called tumor markers, and your doctor may monitor one or more of them during and after treatment.
- PSA for prostate cancer
- CA-125 for ovarian cancer
- CEA for colorectal cancer and some other types
- CA 15-3 or CA 27.29 for breast cancer
- AFP for liver cancer, ovarian cancer, and germ cell tumors
- Calcitonin for medullary thyroid cancer
A tumor marker that drops to normal levels after treatment is a good sign, but it’s not proof that every cancer cell is gone. Some cancers don’t produce reliable markers at all, and marker levels can fluctuate for non-cancer reasons. What doctors watch for is the trend over time. A steady rise in a previously low marker is one of the earliest signals that cancer may be returning, often before anything shows up on a scan.
When a Biopsy Settles the Question
Imaging can find suspicious areas, but it can’t always tell the difference between cancerous tissue and scar tissue left over from treatment. A CT or MRI might show a mass that could be either one. In these situations, a biopsy is the only way to know for certain. A doctor removes a small sample of tissue and a pathologist examines it under a microscope to determine whether cancer cells are present.
Not everyone needs a post-treatment biopsy. It’s typically reserved for cases where imaging results are ambiguous, where a previous needle biopsy was inconclusive, or where the suspicious tissue can’t be evaluated any other way. If your scans are completely clean and your tumor markers are normal, a biopsy usually isn’t necessary.
Newer Blood Tests That Detect Tiny Traces
A newer category of testing looks for fragments of tumor DNA circulating in your bloodstream. These tests can sometimes detect what’s called minimal residual disease: tiny numbers of cancer cells that survive treatment but are too few to show up on any scan. For colorectal cancer patients, this type of testing catches residual disease about 70% of the time at the first post-treatment checkpoint. That sensitivity is promising but imperfect, which is why these tests are used alongside imaging and traditional markers rather than replacing them.
This technology is still evolving, and it’s not available or useful for every cancer type. But for certain cancers, it’s becoming a standard part of follow-up care because it can flag recurrence risk months before symptoms or scan findings appear.
Symptoms That Warrant a Closer Look
Between scheduled follow-up appointments, your own body provides information. Certain symptoms should prompt a call to your care team, especially if they resemble what you experienced before your diagnosis:
- A new lump or bump, particularly near where your cancer originally started
- Pain that persists and doesn’t have an obvious cause
- A cough that won’t go away
- Unexplained weight loss
- Unusual bleeding or bruising
- A fever that lingers without explanation
- Blood in your stool or urine
- Persistent nausea, vomiting, or trouble swallowing
- Frequent headaches or new shortness of breath
Any one of these could have a perfectly ordinary explanation. But after a cancer diagnosis, they’re taken more seriously, and your doctors will want to rule out recurrence quickly rather than wait.
Why the Five-Year Mark Matters
You’ll often hear the five-year survival rate mentioned in cancer statistics. This benchmark exists because for many cancers, recurrence becomes increasingly unlikely after five years of remission. If you reach that point with clean scans and normal markers, the odds shift meaningfully in your favor.
But the five-year mark isn’t a universal finish line. Some cancers, like certain breast cancers and melanoma, can recur a decade or more after treatment. Others, like testicular cancer, have very high cure rates and are considered resolved much sooner. Your specific cancer type, stage at diagnosis, and how completely your treatment eliminated visible disease all shape what the five-year milestone means for you personally.
Follow-up schedules reflect this reality. In the first two to three years after treatment, you’ll typically have scans and blood work every few months. As time passes without recurrence, appointments spread further apart. The gradual stretching of that schedule is itself a signal: your medical team is seeing enough consistent evidence to be increasingly confident that your cancer isn’t coming back.